title: Oestrogen induces c-Ha-ras expression in the fibroblasts derived from human uterine endometrium.
abstract: In this preliminary study, fibroblasts derived from uterine endometrium as a substitute for normal endometrial stroma were used to analyse the stromal role in uterine endometrium, which depends on oestrogen for growth. C-Ha-ras expression and tyrosine kinase (TK) activity in the fibroblasts were increased by oestradiol, and the increase was diminished by progesterone. Epidermal growth factor (EGF), an activator of TK, also increased c-Ha-ras expression. The combination of both oestradiol and EGF at maximum effective concentration exerted no additive and synergistic effect on induction of c-Has-ras expression. Pretreatment with tyrphostin, an inhibitor of TK, abolished the oestrogen-inducible expression of c-Ha-ras. Oestrogen might lead to rapid induction of c-Ha-ras expression in endometrial stroma, at least in part, via the activation of TK for the early stages of oestrogen dependent growth in endometrium.
authors.affiliation: Department of Obstetrics and Gynecology, Gifu University School of Medicine, Japan.
authors.forename: J
authors.initials: J
authors.lastname: Fujimoto
authors.forename: S
authors.initials: S
authors.lastname: Ichigo
authors.forename: M
authors.initials: M
authors.lastname: Hori
authors.forename: S
authors.initials: S
authors.lastname: Morishita
authors.forename: T
authors.initials: T
authors.lastname: Tamaya
mesh_terms: D000328:Adult; D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004717:Endometrium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects; D011905:Genes, ras / Q000235:genetics*; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000235:genetics / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011374:Progesterone / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D017154:Stromal Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D010446:Peptide Fragments; D012333:RNA, Messenger; C068142:glyceraldehyde 3-phosphate dehydrogenase (304-313); D011374:Progesterone; D004958:Estradiol; D004815:Epidermal Growth Factor; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; D011505:Protein-Tyrosine Kinases